Decreased mRNA levels of BDNF were reported in postmortem brain samples, as were changes in BDNF/TrkB signaling, which indicates the impairment of BDNF and its receptor, TrkB, in AD [27]. Here, NTRK2 is linked to Alzheimer disease.